Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × spartalizumab × Clear all

NCT01420965 2019-07-10

Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer

Phase 2 Terminated

7 enrolled 7 charts

Prostatic Neoplasms